New procedure and diagnostic codes added to the private reimbursement schedule in England

In December 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclatures for private payers in England, published Bulletins 0181 and 0078 with changes to be implemented no later than February 01, 2022.

Seven new codes were introduced in procedure nomenclature:

• K0970 Percutaneous covered stent correction of sinus venosus atrial septal defect
• E1435 Cryotherapy or cryoablation of posterior nasal nerve
• V6070 Thoracic outlet decompression surgery
• 20395 Follow-up neuropsychological assessment
• V1072 Partial maxillectomy for benign tumor
• V1073 Hemi-maxillectomy for benign tumor
• V4125 Removal of spinal magnetic growth rods and definitive instrumented spinal fusion (including spinal cord monitoring)

Four new codes were added to diagnostic nomenclature:

• 3548G Gene Panel Kallmann syndrome
• 3549G Gene Panel Batten disease (Neuronal Ceroid Lipofuscinoses)
• 9201B Saline suppression test
• 20395 Follow-up neuropsychological assessment

See the full details here.

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). First EU issues of both newsletters are available for download free-of-charge.

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks).